A chronic schizophrenic patient developed a fatal agranulocytosis 1
month after beginning to take carbamazepine for aggression. Routine
hematological monitoring was not carried out. This case highlights the need
for psychiatrists' increased awareness of the possible hematological
complications of carbamazepine.
Abstract Teaser